Sciacca Gets 1000th Winner

Some four decades after saddling his first winner, trainer Gary Sciacca celebrated the 1000th victory of his career, sending out Caumsett (The Factor) to win the Aqueduct fall meet opener Thursday afternoon. The 47-10 third favorite, Caumsett broke his maiden in a one-mile turf test beneath Hall of Famer Javier Castellano (video).

Sciacca, a two-time leading trainer at Belmont Park (spring 1993 and fall 1997), has conditioned the likes of multiple Grade I winner Saratoga Dew–the first New York-bred to be named an Eclipse champion–and millionaire GISW Subordination.

“I'm just real happy to get it done,” Sciacca, 61 and a Brooklyn native, said. “I would have loved to have got it done at Belmont, but I got my start here at Aqueduct so this is great. It feels great. We needed to get it done and get it over with. I thought she was going to win last time [Sept. 19], but she got nailed right at the wire. Bobby, my son is here, so that's great.”

He added, “The Grade I wins with Saratoga Dew and Subordination were huge. The business has been so great to me and all the hard work is paying off. It's taken me all over and has been really good.”

The post Sciacca Gets 1000th Winner appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Notable US-Breds In Japan: Nov. 13 & 14, 2021

In this continuing series, we take a look ahead at US-bred and/or conceived runners entered for the upcoming weekend at the tracks on the Japan Racing Association circuit, with a focus on pedigree and/or performance in the sales ring. Here are the horses of interest for this weekend running at Tokyo and Hanshin Racecourses. There is one Group 1 on each of the remaining seven weekends in 2021, kicking off with Japan's version of the Queen Elizabeth II Cup for fillies and mares, a race that would have attracted Loves Only You (Jpn), but for her landmark victory at the Breeders' Cup:

Saturday, November 13, 2021
9th-TOK, ¥19,110,000 ($168k), Allowance, 2yo, 1400m
CONCH PEARL (f, 2, American Pharoah–A Z Warrior, by Bernardini), second and third in turf maidens to begin her career, set a track-record time for the class when graduating by eight lengths in a two-turn maiden at Kokura Sept. 4 (see below, SC 7) and exits a narrowly beaten third over this trip at Hanshin Oct. 24. Her 'TDN Rising Star' dam, who sold for $550,000 in foal to Uncle Mo at Keeneland November Wednesday, is also responsible for SW Key To My Heart (Ire) (Galileo {Ire}) and SP Cole Porter (Ire) (Galileo {Ire}). A Z Warrior is a half-sister to fellow 'Rising Stars' Jojo Warrior (Pioneerof the Nile), J Z Warrior (Harlan's Holiday) and E Z Warrior (Exploit). Conch Pearl cost North Hills $340K at KEESEP last fall. B-Triemore Stud (KY)

 

 

Sunday, November 14, 2021
1st-TOK, ¥9,680,000 ($85k), Maiden, 2yo, 1600m
POISON ARROW (c, 2, Arrogate–Crosswinds, by Storm Cat) was well-beaten when debuting on the dirt in July, but perked up a bit in a pair of tries on the turf, including a sound fourth at Sapporo Aug. 21. The $750K KEESEP grad is possessed of an each-way pedigree, as his half-sister Weep No More (Mineshaft) upset the 2016 GI Central Bank Ashland S., while half-brother Current (Curlin) took the GIII Dixiana Bourbon S. in 2018. Poison Arrow's second dam is GI Kentucky Oaks and GI Alabama S. heroine Flute (Seattle Slew), who produced GSW & MGISP turf distaffer Filimbi (Mizzen Mast). B-Hinkle Farms (KY)

1st-HSN, ¥9,860,000 ($85k), Maiden, 2yo, 1400m
SHIRAKINU (f, 2, Frosted–Meets Expectations, by Valid Expectations), a $335K graduate of last year's Fasig-Tipton Selected Yearlings Showcase, fought on bravely from a high gate in her debut, but gave way late to finish second, beaten 3/4 of a length going this distance at Tokyo Oct. 30 (see below, SC 15). The Godolphin colorbearer is a half-sister to dual-surface GISW World of Trouble (Kantharos) and SW Money Or Love (J Be K) and her dam is a half-sister to the multiple graded-stakes winner Bucchero (Kantharos).B-Darsan Inc & Godolphin (FL)

 

The post Notable US-Breds In Japan: Nov. 13 & 14, 2021 appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

They Ran a Lasix Free Breeders’ Cup…And Nothing Happened

The biggest story when it comes to the ban of Lasix in the Breeders' Cup is that there was no story. It was, simply, a non-factor.

A total of 148 horses competed in this year's Breeders' Cup, all of them running Lasix-free. There were no reports of any horses being in distress or bleeding from the nostrils. I did not hear of one trainer blaming a defeat on the ban of the diuretic. Nor did I hear of or read about any trainers saying they were passing the Breeders' Cup because Lasix wasn't being allowed.

And there was a record handle, so, clearly the bettors weren't reluctant to play races without Lasix.

Dr. Jeff Blea, the equine medical director for the California Horse Racing Board, said that he hadn't seen any signs of serious or obvious problems.

“There was no informal data collected to evaluate EIPH in horses that ran on Friday and Saturday,” he said in an email.  “Anecdotally, I had surveyed several of the local attending veterinarians to get an understanding of what they were seeing endoscopically, specifically horses that bled a grade 3 or 4. I'm still waiting on responses from two practitioners, but it doesn't appear that it was a significant problem.

“One practitioner commented that grade 3/4 was noted in less than 10% of the horses he scoped. That said, I don't know his denominator. Others commented that they were surprised that they didn't observe severe episodes of EIPH. Furthermore, to my knowledge, I am not aware of any incidents of epistaxis on those two days.”

What happened to all the dire prognostications, that horsemen would suffer irreparable injury if the drug were taken away from them? That innumerable horses would no longer be able to race without it? That horses would bleed through the nostrils in full view of a horrified public? That it is inhumane to force horses to race without Lasix?

None of that has been proven to be true.

Lasix was banned on 2-year-olds in many jurisdictions in 2020. This year, it was also banned in graded stakes races at most of the top tier tracks. This year's Triple Crown was also contested Lasix-free, also without any problems. There is not much available so far in the way of data regarding how horses fared without Lasix, but, just as was the case with the Breeders' Cup, the number of serious problems appear to have been minimal. The sport simply adjusted and moved on.

By the time we got to the Breeders' Cup, the Lasix debate, once among the most controversial subjects in the game, had turned into a non-issue. Probably a lot of you never even took it into account that this Breeders' Cup would be contested without the diuretic. That's because the results of this year's Lasix-free races have proved that taking it away is, well, no big deal.

That's just it. Is Lasix really necessary? Trainers no longer give it just to bleeders but to every horse in their barn. It became a matter of not preventing bleeding but not allowing the competition to have an edge on you.

Racing is conducted everywhere else in the world without it and American racing had done just fine without it for one-hundred-plus years before its use became widespread in the 80s.

So why allow it? It's been evident for a long time that U.S. racing is too dependant on drugs, which has created an image problem for an industry that keeps on having to prove that it is on the level and that it is safe.

But my biggest problem with Lasix is that there is credible evidence that it is a major factor when it comes to why horses race so infrequently these days. In 1970, before Lasix had permeated racing's landscape, the average number of starts per runner per year was 10.22. It's now down to about 6.15.

The slide in the number of average starters per year began just about the same time that Lasix started being legalized across the country. That's not surprising since Lasix's is a diuretic that acts to dehydrate horses. When dehydrated, a race takes something extra out of a horse and they need more time to recover. That's just common sense.

That's anecdotal evidence that Lasix has contributed to a situation where we have the most unhealthy, least durable collection of horses ever seen in modern times.

The good news is that there are more changes on the horizon. When the Horseracing Safety and Integrity Act (HISA) goes into effect, the clock will start ticking on the drug. Under HISA, a racing commission that wants to prolong Lasix use can do so for three years. After the three-year period, a unanimous vote from HISA would be needed to continue the legal use of the drug. It's on its way out.

Yes, the sport has many problems that are a lot more serious than the use of Lasix. We've seen that with the rash of breakdowns at Santa Anita in 2019 and the 2020 indictments of trainers Jason Servis, Jorge Navarro and others on charges that they were using performance-enhancing drugs. That doesn't mean that the sport can't assess each issue independently and act. Getting rid of Lasix won't solve all the drug issues, but it's a step in the right direction and the right thing to do.

And horsemen, those who were predicting doomsday scenarios, can relax. They will do just fine without the drug. This year's Breeders' Cup proved just that.

The post They Ran a Lasix Free Breeders’ Cup…And Nothing Happened appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Great American Stallion Season Sale Set for January

The sixth annual Jockeys and Jeans Great American Stallion Season Sale to benefit the Permanently Disabled Jockeys Fund will take place Jan. 21 through Jan. 24, 2022, on the Starquine.com platform. A preview of the available seasons–both Thoroughbred and Quarter Horse–will be made available Jan. 20. All seasons are non-guaranteed and donors have the option of including a breed-back provision the following year if the mare does not get in foal.

“We are tickled to see that the racing industry is on the rebound from the pandemic year and the sport we all know and love is regaining its health,” said Jockeys and Jeans President Barry Pearl. “Our season sale not only offers solid stallions at a reasonable cost, but more importantly, the opportunity to make a difference in those who gave a big part of their lives to horse racing.”

Since its founding in 2014 by a group of former jockeys, Jockeys and Jeans has raised $1.9 million. All proceeds from the auction go to the PDJF. The charity provides a $1000 monthly stipend to some 60 former jockeys who suffered career-ending injuries, at least 40 of whom are quadra- or para-plegics.

The post Great American Stallion Season Sale Set for January appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Verified by MonsterInsights